IN2012CN10302A - - Google Patents
Download PDFInfo
- Publication number
- IN2012CN10302A IN2012CN10302A IN10302CHN2012A IN2012CN10302A IN 2012CN10302 A IN2012CN10302 A IN 2012CN10302A IN 10302CHN2012 A IN10302CHN2012 A IN 10302CHN2012A IN 2012CN10302 A IN2012CN10302 A IN 2012CN10302A
- Authority
- IN
- India
- Prior art keywords
- apo
- solvate forms
- warfarin potassium
- polymorphic
- termed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
There is provided crystalline solvate forms of Warfarin potassium termed APO I and APO II and processes for making APO I and APO II. APO I and APO II are polymorphic solvate forms of Warfarin potassium.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34668010P | 2010-05-20 | 2010-05-20 | |
PCT/CA2011/000572 WO2011143747A1 (en) | 2010-05-20 | 2011-05-20 | Polymorphic forms of warfarin potassium and preparations thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012CN10302A true IN2012CN10302A (en) | 2015-06-12 |
Family
ID=44991119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN10302CHN2012 IN2012CN10302A (en) | 2010-05-20 | 2011-05-20 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8765976B2 (en) |
EP (1) | EP2571861A4 (en) |
CA (1) | CA2800016A1 (en) |
IN (1) | IN2012CN10302A (en) |
WO (1) | WO2011143747A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6512005B2 (en) * | 2001-02-28 | 2003-01-28 | Taro Pharmaceutical Industries, Ltd. | Process for synthesis of pure warfarin acid, warfarin alkali metal salts and corresponding clathrates |
MXPA03007769A (en) * | 2001-02-28 | 2005-07-01 | Taro Pharmaceuticals Usa Inc | Process for purification of warfarin acid, warfarin alkali metal salts and corresponding clathrates. |
US6673944B2 (en) * | 2001-02-28 | 2004-01-06 | Taro Pharmaceutical Industries, Ltd. | Preparation of warfarin sodium from warfarin acid |
-
2011
- 2011-05-20 CA CA2800016A patent/CA2800016A1/en not_active Abandoned
- 2011-05-20 US US13/699,293 patent/US8765976B2/en not_active Expired - Fee Related
- 2011-05-20 WO PCT/CA2011/000572 patent/WO2011143747A1/en active Application Filing
- 2011-05-20 IN IN10302CHN2012 patent/IN2012CN10302A/en unknown
- 2011-05-20 EP EP11782804.6A patent/EP2571861A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2571861A1 (en) | 2013-03-27 |
CA2800016A1 (en) | 2011-11-24 |
EP2571861A4 (en) | 2013-10-30 |
US8765976B2 (en) | 2014-07-01 |
US20130143957A1 (en) | 2013-06-06 |
WO2011143747A1 (en) | 2011-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267629A (en) | Method of culturing eukaryotic cells | |
TWI563079B (en) | Process for fermentation of syngas | |
ZA201300133B (en) | Process for fractionation of biomass | |
PL2766489T3 (en) | Method for production of microbial output | |
MX342851B (en) | Methods and materials for enzymatic synthesis of mogroside compounds. | |
CR20120565A (en) | INDOLES | |
AU2012289429A8 (en) | Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof | |
EP2678512A4 (en) | Method of high power laser-mechanical drilling | |
EP2636731A4 (en) | Method of producing intestinal cells | |
PL3070170T3 (en) | Fermentation of co2 by using an electrical potential | |
PT2609071T (en) | New process for the preparation of intermediates useful for the manufacture of nep inhibitors | |
DK2569438T3 (en) | METHOD OF PRODUCING BIOGAS | |
EP2673637A4 (en) | Determination of oocyte quality | |
HK1202224A1 (en) | Biomarkers of response to nae inhibitors nedd8 (nae) | |
EP2499151A4 (en) | Mammalian metabolites of steroids | |
EP2423203A4 (en) | Crystal of benzoxazinone compound | |
IL233355A (en) | Methods of synthesizing and isolating (4-chloro-2-fluoro-3-substituted-phenyl)boronates | |
EP2621699A4 (en) | Sawing apparatus of single crystal ingot | |
GB201010644D0 (en) | Recycling of enzymes from bioreactors | |
HK1177931A1 (en) | 2 -amino- pyrimidine derivatives useful as inhibitors of jnk jnk 2-- | |
EP2561365A4 (en) | Methods of identifying & using anti-viral compounds | |
IN2012CN10302A (en) | ||
MY172885A (en) | Novel crystal form | |
AU2010902824A0 (en) | Method of screening for inhibitors of sPLA2-IIA | |
AU2012208061A8 (en) | Instrument for producing kakiage and method for producing kakiage |